Hong Kong billionaire Li Ka-shing funds Asia's first scalpel-free kidney tumour trials
Billionaires Africa | 12.11.2026 14:47
Hong Kong billionaire Li Ka-shing is funding 30 places in Asia's first clinical trials of histotripsy for kidney tumours, extending his push to bring the scalpel-free cancer treatment to the region beyond liver and pancreatic cancers.
